Most lately, it has been identified that conolidine and the above mentioned derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in related locations as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts as a scavenger and won't activate a second messeng